Gentian Diagnostics ASA (OSL:GENT)
Norway flag Norway · Delayed Price · Currency is NOK
55.00
-2.00 (-3.51%)
May 9, 2025, 4:26 PM CET

Gentian Diagnostics ASA Revenue

Gentian Diagnostics ASA had revenue of 44.50M NOK in the quarter ending March 31, 2025, with 15.58% growth. This brings the company's revenue in the last twelve months to 158.07M, up 11.14% year-over-year. In the year 2024, Gentian Diagnostics ASA had annual revenue of 152.07M with 12.52% growth.

Revenue (ttm)
158.07M
Revenue Growth
+11.14%
P/S Ratio
5.37
Revenue / Employee
2.51M
Employees
63
Market Cap
848.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024152.07M16.92M12.52%
Dec 31, 2023135.15M23.23M20.76%
Dec 31, 2022111.92M11.91M11.91%
Dec 31, 2021100.01M21.13M26.78%
Dec 31, 202078.88M23.50M42.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Medistim ASA 556.16M
Nordhealth AS 537.23M
Photocure ASA 532.69M
Vistin Pharma ASA 440.66M
Nykode Therapeutics AS 104.04M
Hofseth BioCare ASA 265.54M
Omda AS 426.27M
ArcticZymes Technologies ASA 102.97M
Revenue Rankings